More Sitting Tied to Greater Death Risk in Older Women
By Lori Solomon HealthDay Reporter
THURSDAY, Feb. 29, 2024 -- Higher total sitting time and longer mean sitting bout duration are associated with higher all-cause and cardiovascular disease (CVD) mortality risk among older women, according to a study published online Feb. 27 in the Journal of the American Heart Association.
Steve Nguyen, Ph.D., from the University of California, San Diego, and colleagues examined the prospective associations of convolutional neural network hip accelerometer posture-classified total sitting time and mean sitting bout duration with all-cause and CVD death in older women. The analysis included 5,856 participants (mean age, 79 years) in the Women’s Health Initiative Objective Physical Activity and Cardiovascular Health Study (median, 8.4 years of follow-up).
The researchers found that risks for all-cause death and CVD death were higher for women in the highest total sitting time quartile (>11.6 hours/day) versus the lowest (<9.3 hours/day; adjusted hazard ratios [aHRs], 1.57 and 1.78, respectively). Similar risk was seen when comparing women in the longest mean sitting bout duration quartile (>15 minutes) to the shortest (<9.3 minutes; all-cause death: aHR, 1.43; CVD death: aHR, 1.52). Based on apparent nonlinear associations for total sitting time, higher all-cause death and CVD death risk occurred after approximately 660 to 700 minutes/day.
"Reducing overall sedentary behavior and interrupting prolonged sitting in addition to promoting physical activity could have large public health benefits in an aging society," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Read this next
342 Cardiology Clinics Acquired by Private Equity Firms in 2013 to 2023
WEDNESDAY, July 3, 2024 -- From 2013 to 2023, 342 cardiology clinics were acquired by private equity firms, with 94.7 percent of the acquisitions occurring between 2021 and 2023...
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.